Cancer Survival Current Events | Cancer Survival News | 10
|
| Page
10 of
124 |
2464 Results |
|
|
|
Sort By:
Page Views | Date |
New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. view more (2008-07-24)
Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma
Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies. view more (2009-07-29)
Tumor response may not be best measure of efficacy in non-small cell lung cancer treatment
Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness. view more (2006-06-06)
Researchers uncover how prostate cancer cells defy death
New findings about how prostate cancer cells are able to resist hormone treatment and defy death may lead to more effective drug treatments. view more (2006-07-31)
Support groups don't extend survival of metastatic breast cancer patients, Stanford study finds
A new study from a team of Stanford University School of Medicine researchers led by David Spiegel, MD, shows that participating in support groups doesn't extend the lives of women with metastatic breast cancer. view more (2007-07-23)
Researchers identify four new targets for breast cancer
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell. view more (2009-06-11)
Cancer patients' quality of life directly relates to their survival
Patients who feel better live longer, say Mayo Clinic researchers, working with the North Central Cancer Treatment Group (NCCTG), in study results released May 15 as part of the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO). view more (2008-05-16)
Finding of a new molecular marker of resistance to chemotherapy in breast cancer
A collaborative study between the IDIBAPS—Hospital Clínic of Barcelona and the Hospital del Mar de Barcelona permits to establish a predictive factor in the resistance to chemotherapy in breast cancer and to establish possible therapeutic targets for the improvement of this treatment. view more (2006-06-29)
Bowel cancer indicator should lead to better treatment
STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. view more (2008-08-20)
Gemcitabine and capecitabine improved overall survival in patients with advanced pancreatic cancer
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. view more (2005-11-03)
Shorter ambulance response times would cut heart attack deaths
Reducing ambulance response times to 5 minutes could almost double the survival rate for cardiac arrests not witnessed by ambulance crews, finds a study in this week's BMJ. All out of hospital cardiopulmonary arrests due to cardiac disease attended by the Scottish Ambulance Service during May 1991 to March 1998 were analysed to determine the... view more... (2001-06-06)
Stem cell indicator for bowel cancer should lead to better survival rates
Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK. view more (2008-08-20)
Complementary and alternative therapies can be harmful and should be tested rigorously before widespread use by patients
Hamburg, Germany: More and more women are turning to complementary and alternative therapies during and after treatment for breast cancer, yet few of these therapies have been adequately evaluated and some may be positively dangerous, the 4th European Breast Cancer Conference heard today (Friday 19 March). Dr Eric Winer, an associate professor of... view more... (2004-03-17)
Inappropriate sepsis therapy leads to fivefold reduction in survival
Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. view more (2009-11-05)
Worsening anemia signals poorer outcomes in men treated for advanced prostate cancer
Researchers from the Oregon Health & Science University Cancer Institute and Southwest Oncology Group have identified a new method of determining how men with advanced prostate cancer will respond to treatment. view more (2006-05-24)
Vaccine shows promise for kidney cancer (pp 583, 594)
Results of a phase III study from Germany in this week's issue of THE LANCET suggest that a tumour-based vaccine could reduce disease recurrence and increase survival of patients who have had surgery for kidney cancer. 3% of cancer occurs in the kidney, with around 12,000 renal-cancer deaths a year in the USA. Removal of part or all of the kidney... view more... (2004-02-18)
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. view more (2009-07-02)
PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool. view more (2007-10-10)
Newer chemotherapies improve outcomes for some types of breast cancer
An updated analysis of findings from three major consecutive clinical trials of breast cancer treatment conducted over the past twenty years indicates that women who have breast cancer with lymph node involvement and estrogen-receptor negative tumors have a lower rate of recurrence and risk of death with treatment with newer chemotherapies. view more (2006-04-12)
Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. view more (2009-11-03)
|
|
| Page
10 of
124 |
2464 Results |
|
|
|
Sort By:
Page Views | Date |
|
